Clinical Edge Journal Scan

HPV infection, HPV immunization, and RA prevalence: What is the link?


 

Key clinical point: Human papillomavirus (HPV) infection was associated with an increased prevalence of rheumatoid arthritis (RA), whereas HPV immunization lowered RA prevalence in adults aged 18-59 years.

Major finding: A significant association was observed between HPV infection and increased prevalence of RA (adjusted odds ratio [aOR] 1.074; 95% CI 1.071-1.076), whereas HPV immunization was associated with a significantly reduced RA prevalence (aOR 0.477; 95% CI 0.472-0.481).

Study details: Findings are from a population-based cohort study including adults age 18-59 years with complete data on HPV infection and history of RA (n = 15,677) and those with complete data on HPV vaccination and history of RA (n = 8944).

Disclosures: This study was supported by the Nanjing Medical University Science, China, and Technology Development Fund and other sources. The authors declared no conflicts of interest.

Source: Yang G et al. Association between human papillomavirus infection or immunization and risk for rheumatoid arthritis. Front Immunol. 2023;14:1130217 (Apr 14). Doi: 10.3389/fimmu.2023.1130217

Recommended Reading

Looking at diseases associated with RA, May 2023
MDedge Rheumatology
Researchers seek to understand post-COVID autoimmune disease risk
MDedge Rheumatology
FDA puts partial hold on investigational alopecia areata drug deuruxolitinib
MDedge Rheumatology
Normal CRP during RA flares: An ‘underappreciated, persistent phenotype’
MDedge Rheumatology
Rheumatoid arthritis linked to increased Parkinson’s risk
MDedge Rheumatology
Investigational drug peresolimab shows efficacy in patients with RA
MDedge Rheumatology
Strong link between polycyclic aromatic hydrocarbons and raised rheumatoid arthritis risk
MDedge Rheumatology
Joint damage repair: A rare phenomenon in early RA
MDedge Rheumatology
Tofacitinib withdrawal not a universal option for all patients with RA in remission
MDedge Rheumatology
Factors guiding sustained remission after withdrawal of combination therapy in RA
MDedge Rheumatology